Abstract
Biotechnology has revolutionized the landscape of drug discovery and development, enabling the creation of highly specific, effective, and personalized therapeutics. From monoclonal antibodies to gene therapy, biotechnological innovations have shortened timelines, enhanced precision, and allowed for the targeting of previously undruggable conditions. This article explores the multifaceted role of biotechnology in the pharmaceutical pipeline, emphasizing molecular techniques, high-throughput screening, computational biology, and biomanufacturing. The integration of genomics, proteomics, and bioinformatics has significantly improved target identification and drug design, ultimately improving therapeutic outcomes and reducing adverse effects. Furthermore, the paper discusses emerging biotechnological trends such as CRISPR, biosimilars, and cell-based assays, which are poised to define the future of drug development.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Dr. Ahsan Khalid (Author)